Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for synthesizing tetrabenazine

A technology of tetrabenazine and a synthesis method, which is applied in the field of medicinal chemical synthesis, can solve the problems of high cost of recovery solvent, high cost of raw materials, difficult filtration, etc., achieves good industrial application prospects, improves regional selectivity, and saves cost of raw materials. Effect

Inactive Publication Date: 2013-02-20
JIANGSU JIMING PHARMA TECH
View PDF3 Cites 26 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The disadvantage of this method is that the preparation yield of 3-isobutyl-3-buten-2-one is very low, easy to polymerize, and more toxic
The shortcoming of this method is that when 5-methyl-2-hexanone carries out Mannich reaction to prepare 3-[(dimethylamino)methyl]-5-methyl-2-hexanone, generate isomer 1-(di Methylamino)-6-methyl-3-heptanone (content as high as 30%), and the boiling point of the isomer is close to that of the product, so it cannot be purified by rectification, which makes purification difficult and requires column chromatography to separate and purify , and the reaction yield is extremely low (16%), it is necessary to recycle excess 5-methyl-2-hexanone raw material
The disadvantage of this method is that the preparation of 3-[(dimethylamino)methyl]-5-methyl-2-hexanone requires the use of expensive 1-bromo-2-methylpropane and the use of a large amount of potassium carbonate And a large amount of methyl tert-butyl ether solvent, difficult to filter, many and complicated operation steps, low yield (20%), the above shortcomings lead to high raw material costs, high solvent recovery costs, and a large amount of solid waste; Synthesis of butylbenzene During nazine, use a large amount of acetone as solvent, and yield is lower

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for synthesizing tetrabenazine
  • Method for synthesizing tetrabenazine
  • Method for synthesizing tetrabenazine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0024] A kind of synthetic method of tetrabenazine of the present embodiment, comprises the following steps:

[0025] (1) Synthesis of Tetramethylmethylenediamine

[0026] In a 1 L three-necked flask, add 162 g of formaldehyde aqueous solution, and after cooling to 0-5 °C, slowly add 545 g of dimethylamine aqueous solution dropwise. Naturally warm up to room temperature (28°C), and stir for 8 hours. After the reaction solution was cooled to 0-5 °C, 250 g of potassium hydroxide solid was slowly added, and the organic phase was separated and dried with 50 g of sodium hydroxide. After filtration, the organic phase was distilled at atmospheric pressure to obtain 172 g of tetramethylmethylenediamine, with a yield of 84% and a purity of 99% by HPLC.

[0027] (2) Synthesis of 3-[(dimethylamino)methyl]-5-methyl-2-hexanone

[0028] In a 1 L three-necked flask, add 240 ml of N,N-dimethylformamide and 122 g of tetramethylmethylenediamine, after cooling to 0-5 °C, add 94 g of acetyl ch...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for synthesizing tetrabenazine. The method comprises: step one, using a dimethylamine aqueous solution and a formaldehyde aqueous solution as initial materials to be reacted1 to obtain tetramethyl methane diamine; step two, dissolving the tetramethyl methane diamine obtained in the step one in an organic solvent, dropwise adding acetyl chloride and 5- methyl-2-hexanone, and performing amine methylation to obtain an intermediate 3-[(dimethyl amino) methyl]-5-methyl-2-hexanone; and step three, reacting the 3-[(dimethyl amino) methyl]-5-methyl-2-hexanone obtained in the step two with 6,7-dimethoxy-3,4-dihydroisoquinoline hydrochloride to obtain the tetrabenazine. According to the method for synthesizing tetrabenazine, the cheap and accessible materials are used as the initial materials, imine salts serve as amine methylation reagents to perform amine methylation reaction on the 5- methyl-2-hexanone, and accordingly, the region-selectivity of chemical reactions is improved; and water serves as a reaction solvent to prepare the tetrabenazine, so that the operation is simple and convenient, no complex post-processing process exists, and good industrial application prospects are provided.

Description

technical field [0001] The invention belongs to the field of pharmaceutical chemical synthesis, in particular to a synthetic method of tetrabenazine. Background technique [0002] Tetrabenazine was first listed in Switzerland and was initially used for the treatment of schizophrenia. In August 2008, it was approved by the U.S. Food and Drug Administration (FDA) for fast-track approval, becoming the first and only drug for the treatment of Huntington's disease (HD) in the United States. HD is an inherited, fatal, degenerative brain disease characterized by personality changes, slurred speech, emotional lability, involuntary movements, and drunkenness. Usually occurs in middle age. Due to the death of cells in the caudate nucleus of the brain, the ability to speak, move, think and swallow is gradually lost. The disease will continue to develop for about 15 to 20 years and eventually lead to death. Tetrabenazine produces pharmacological activity mainly by reversibly inhibitin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D455/06
Inventor 陈剑戈李斌峰邓建
Owner JIANGSU JIMING PHARMA TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products